Urine Analyzers - Medical Devices Pipeline Assessment, 2017

GlobalData
31 Pages - GLDATA60418
$2,500.00

Summary

GlobalData's Medical Devices sector report, “Urine Analyzers - Medical Devices Pipeline Assessment, 2017" provides an overview of Urine Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Urine Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Urine Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Urine Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Urine Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Analyticon Biotechnologies AG
Biosense Technologies Pvt Ltd.
Erba Diagnostics, Inc.
Roche Diagnostics International Ltd
Siemens Healthcare GmbH
Sysmex Corp
Teco Diagnostics

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Urine Analyzers Overview 4
3 Products under Development 5
3.1 Urine Analyzers - Pipeline Products by Stage of Development 5
3.2 Urine Analyzers - Pipeline Products by Territory 6
3.3 Urine Analyzers - Pipeline Products by Regulatory Path 7
3.4 Urine Analyzers - Pipeline Products by Estimated Approval Date 8
3.5 Urine Analyzers - Ongoing Clinical Trials 9
4 Urine Analyzers - Pipeline Products under Development by Companies 10
4.1 Urine Analyzers Companies - Pipeline Products by Stage of Development 10
4.2 Urine Analyzers - Pipeline Products by Stage of Development 11
5 Urine Analyzers Companies and Product Overview 12
5.1 Analyticon Biotechnologies AG Company Overview 12
5.1.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Biosense Technologies Pvt Ltd. Company Overview 13
5.2.1 Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Erba Diagnostics, Inc. Company Overview 16
5.3.1 Erba Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Roche Diagnostics International Ltd Company Overview 17
5.4.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Siemens Healthcare GmbH Company Overview 18
5.5.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Sysmex Corp Company Overview 19
5.6.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Teco Diagnostics Company Overview 23
5.7.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23
6 Urine Analyzers- Recent Developments 24
6.1 Feb 22, 2017: U.S. ARKRAY announces the launch of the AUTION ELEVEN AE-4022 Semi-Automated Urine Analyzer 24
6.2 Nov 29, 2016: ERBA Diagnostics names interim CEO 24
6.3 Nov 10, 2016: Siemens Healthcare Plans IPO of Shares 25
6.4 Oct 13, 2016: Eric Riley joins Streck as Human Resources Director 25
6.5 Jul 04, 2016: Easywell Biomedical Raises USD6.2 Million in Public Offering of Bonds Due 2019 25
6.6 Jul 04, 2016: Easywell Biomedical to Raise USD13 Million in Public Offering of Shares 25
6.7 Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 26
6.8 May 31, 2016: ERBA Diagnostics Announces Extension of CEO’S Contract Term and Appointment of Hayden Jeffreys to Board of Directors 26
6.9 May 20, 2016: ERBA Diagnostics Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan 26
7 Appendix 28
7.1 Methodology 28
7.2 About GlobalData 31
7.3 Contact Us 31
7.4 Disclaimer 31

1.1 List of Tables
Table 1: Urine Analyzers - Pipeline Products by Stage of Development 5
Table 2: Urine Analyzers - Pipeline Products by Territory 6
Table 3: Urine Analyzers - Pipeline Products by Regulatory Path 7
Table 4: Urine Analyzers - Pipeline Products by Estimated Approval Date 8
Table 5: Urine Analyzers - Ongoing Clinical Trials 9
Table 6: Urine Analyzers Companies - Pipeline Products by Stage of Development 10
Table 7: Urine Analyzers - Pipeline Products by Stage of Development 11
Table 8: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 12
Table 9: CombiScan XL - Product Status 12
Table 10: CombiScan XL - Product Description 12
Table 11: Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 13
Table 12: uChek Universal - Product Status 13
Table 13: uChek Universal - Product Description 13
Table 14: Biosense Technologies Pvt Ltd. - Ongoing Clinical Trials Overview 14
Table 15: uChek Universal - A Prospective Observational Pilot Study to Test the Feasibility of Smartphone Enabled uChek Urinalysis Device in Bangladesh 15
Table 16: Erba Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 17: Laura XL - Product Status 16
Table 18: Laura XL - Product Description 16
Table 19: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
Table 20: Cobas 6500 Analyzer - Product Status 17
Table 21: Cobas 6500 Analyzer - Product Description 17
Table 22: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 18
Table 23: Clinitek Atlas Next - Product Status 18
Table 24: Clinitek Atlas Next - Product Description 18
Table 25: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 19
Table 26: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Status 19
Table 27: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Description 20
Table 28: UC-3500 - Product Status 20
Table 29: UC-3500 - Product Description 21
Table 30: UF-5000 - Product Status 21
Table 31: UF-5000 - Product Description 22
Table 32: Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23
Table 33: Next Generation Urine Analyzer - Product Status 23
Table 34: Next Generation Urine Analyzer - Product Description 23
Table 35: Glossary 30

1.2 List of Figures
Figure 1: Urine Analyzers - Pipeline Products by Stage of Development 5
Figure 2: Urine Analyzers - Pipeline Products by Territory 6
Figure 3: Urine Analyzers - Pipeline Products by Regulatory Path 7
Figure 4: Urine Analyzers - Pipeline Products by Estimated Approval Date 8
Figure 5: Urine Analyzers - Ongoing Clinical Trials 9

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838